rs137933845

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001012759.3(CTU2):​c.25G>A​(p.Gly9Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0181 in 1,458,604 control chromosomes in the GnomAD database, including 272 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 22 hom., cov: 33)
Exomes 𝑓: 0.019 ( 250 hom. )

Consequence

CTU2
NM_001012759.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.792

Publications

5 publications found
Variant links:
Genes affected
CTU2 (HGNC:28005): (cytosolic thiouridylase subunit 2) This gene encodes a protein which is involved in the post-transcriptional modification of transfer RNAs (tRNAs). The encoded protein plays a role in thiolation of uridine residue present at the wobble position in a subset of tRNAs, resulting in enhanced codon reading accuracy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
RNF166 (HGNC:28856): (ring finger protein 166) Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in protein polyubiquitination and ubiquitin-dependent protein catabolic process. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023970008).
BP6
Variant 16-88706555-G-A is Benign according to our data. Variant chr16-88706555-G-A is described in ClinVar as [Benign]. Clinvar id is 1529311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0135 (2054/152140) while in subpopulation NFE AF = 0.0215 (1458/67950). AF 95% confidence interval is 0.0205. There are 22 homozygotes in GnomAd4. There are 949 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTU2NM_001012759.3 linkc.25G>A p.Gly9Arg missense_variant Exon 1 of 15 ENST00000453996.7 NP_001012777.1 Q2VPK5-1
RNF166NM_178841.4 linkc.-230C>T upstream_gene_variant ENST00000312838.9 NP_849163.1 Q96A37-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTU2ENST00000453996.7 linkc.25G>A p.Gly9Arg missense_variant Exon 1 of 15 1 NM_001012759.3 ENSP00000388320.2 Q2VPK5-1
RNF166ENST00000312838.9 linkc.-230C>T upstream_gene_variant 1 NM_178841.4 ENSP00000326095.4 Q96A37-1

Frequencies

GnomAD3 genomes
AF:
0.0135
AC:
2055
AN:
152032
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00328
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0134
Gnomad ASJ
AF:
0.0237
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00870
Gnomad FIN
AF:
0.00802
Gnomad MID
AF:
0.0318
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0152
AC:
1069
AN:
70398
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.00229
Gnomad AMR exome
AF:
0.00772
Gnomad ASJ exome
AF:
0.0250
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0211
Gnomad OTH exome
AF:
0.0187
GnomAD4 exome
AF:
0.0186
AC:
24330
AN:
1306464
Hom.:
250
Cov.:
31
AF XY:
0.0184
AC XY:
11835
AN XY:
644460
show subpopulations
African (AFR)
AF:
0.00241
AC:
63
AN:
26130
American (AMR)
AF:
0.00960
AC:
223
AN:
23238
Ashkenazi Jewish (ASJ)
AF:
0.0227
AC:
518
AN:
22788
East Asian (EAS)
AF:
0.0000355
AC:
1
AN:
28144
South Asian (SAS)
AF:
0.00938
AC:
669
AN:
71350
European-Finnish (FIN)
AF:
0.0112
AC:
367
AN:
32688
Middle Eastern (MID)
AF:
0.0224
AC:
88
AN:
3922
European-Non Finnish (NFE)
AF:
0.0206
AC:
21476
AN:
1044164
Other (OTH)
AF:
0.0171
AC:
925
AN:
54040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1209
2418
3626
4835
6044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0135
AC:
2054
AN:
152140
Hom.:
22
Cov.:
33
AF XY:
0.0128
AC XY:
949
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00327
AC:
136
AN:
41538
American (AMR)
AF:
0.0133
AC:
204
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
82
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5144
South Asian (SAS)
AF:
0.00870
AC:
42
AN:
4826
European-Finnish (FIN)
AF:
0.00802
AC:
85
AN:
10602
Middle Eastern (MID)
AF:
0.0308
AC:
9
AN:
292
European-Non Finnish (NFE)
AF:
0.0215
AC:
1458
AN:
67950
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
111
221
332
442
553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0135
Hom.:
3
Bravo
AF:
0.0134
ESP6500AA
AF:
0.00182
AC:
5
ESP6500EA
AF:
0.0127
AC:
73
ExAC
AF:
0.00614
AC:
427
Asia WGS
AF:
0.00232
AC:
9
AN:
3468

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CTU2-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
14
DANN
Benign
0.93
DEOGEN2
Benign
0.0053
T;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.00018
N
LIST_S2
Benign
0.67
T;T;T
MetaRNN
Benign
0.0024
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.61
N;N;.
PhyloP100
-0.79
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.031
Sift
Benign
0.41
T;T;T
Sift4G
Benign
0.14
T;T;T
Polyphen
0.0060
B;B;.
Vest4
0.015
MutPred
0.10
Loss of relative solvent accessibility (P = 0.0676);Loss of relative solvent accessibility (P = 0.0676);Loss of relative solvent accessibility (P = 0.0676);
ClinPred
0.0044
T
GERP RS
1.1
PromoterAI
-0.036
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.077
gMVP
0.29
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137933845; hg19: chr16-88772963; COSMIC: COSV100371892; COSMIC: COSV100371892; API